Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema

Inclusion Criteria: * Mild to moderate hand eczema for at least 3 months * At least 4 weeks have passed since use of systemic treatment for eczema * At least 4 weeks have passed since any vaccination * At least 1 week has passed since last topic treatment on hands with corticosteroids * Agree to use adequate contraceptive method if of childbearing potential * Willingness to avoid excessive exposure to sunlight and avoid skin irritants Exclusion Criteria: * Pregnancy, breast feeding * Severe excoriations on the hands * Need for systemic treatment for atopic dermatitis * Known sensitivity to Zarzenda and/or to extract of nut butyrospermum parkii (shea) * Known immune deficiency * Concomitant infection on hands